Uncategorized

Cytovation ASA, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumor membrane immunotherapy CyPep-1, announces the successful closing of its $8 million Series A extension financing round.

Evotec SE announced that the Company has received a $ 1.7 m grant from Open Philanthropy, a philanthropic funder prioritising global health and wellbeing.

Vanda Pharmaceuticals Inc. announced participation at SLEEP 2023, to be held in Indianapolis, IN from June 3 – 7, 2023.

Akeso Inc. announced that China’s National Medical Products Administration has accepted its New Drug Application for its fully human anti-PCSK9 monoclonal antibody ebronucimab for 2 indications 1) primary hypercholesterolemia and mixed hyperlipidemia, and 2) heterozygous familial hypercholesterolemia.

CANbridge Pharmaceuticals, Inc. announced that the Chinese National Medical Products Administration has approved CAN108 to be marketed for the treatment of cholestatic pruritus in patients with Alagille syndrome 1 year of age and older.

Medivir AB announces that a safe dose has been established for treatment with the drug candidate fostroxacitabine bralpamide in combination with Keytruda® in the initial dose escalation part of the company’s 1b/2a study in hepatocellular carcinoma.

A KFF analysis of 11 states found many of the people who have already been removed from the Medicaid program were disenrolled for procedural reasons.

Roger Perlmutter’s company announced the addition Thursday of myriad early- to mid-stage assets in the cancer and neurodegenerative disease spaces.

IRhythm can continue to manufacture and sell its products and does not expect the warning letter to materially affect its financial results.

The pharma company said it will work with startups and other digital health companies as well as add to its own capabilities as it builds out the consumer-focused business unit.